nebiten
g.l. pharma gmbh - nebivololis - tabletės - 5 mg - nebivolol
nebivolol orion
orion corporation - nebivololis - tabletės - 5 mg - nebivolol
nebivolol portfarma
portfarma ehf. - nebivololis - tabletės - 5 mg - nebivolol
eglonyl
lex ano, uab - sulpiridas - tabletės - 200 mg - sulpiride
eglonyl
actiofarma, uab - sulpiridas - tabletės - 200 mg - sulpiride
xalkori
pfizer europe ma eeig - krizotinibas - karcinoma, nesmulkiųjų ląstelių skausmas - antinavikiniai vaistai - xalkori as monotherapy is indicated for:the first‑line treatment of adults with anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with previously treated anaplastic lymphoma kinase (alk)‑positive advanced non‑small cell lung cancer (nsclc)the treatment of adults with ros1‑positive advanced non‑small cell lung cancer (nsclc)the treatment of paediatric patients (age ≥6 to.
corvitol
berlin-chemie ag (menarini group) - metoprololio tartratas - tabletės - 50 mg - metoprolol
metoprolol-egis
egis pharmaceuticals plc - metoprololio tartratas - tabletės - 50 mg; 25 mg; 100 mg - metoprolol
metoprolol succinate accord [metotifi]
accord healthcare limited - metoprololio sukcinatas - pailginto atpalaidavimo tabletės - 95 mg; 190 mg - metoprolol
prosulpin
pro. med. cs praha a.s. - sulpiridas - tabletės - 200 mg - sulpiride